InvestorsHub Logo
Followers 800
Posts 50868
Boards Moderated 2
Alias Born 12/12/2004

Re: None

Tuesday, 05/04/2021 8:05:28 AM

Tuesday, May 04, 2021 8:05:28 AM

Post# of 158
PT > $20. > Stifel analyst Dae Gon Ha initiates coverage on ProQR Therapeutics (NASDAQ:PRQR) with a Buy rating and announces Price Target of $20.

New York Yankees and Duke Basketball

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PRQR News